Episode 26 - Tofacitinib (Xeljanz) long-term safety data

Follow up

Apremilast (Otezla)

Contest winner

We had a lot of great entries, some of which will end up as future topics, including today.

The winner by random selection was th3o6a1d, author of MED*T3CH.

Congratulations to th3o6a1d and our thanks to Medelita, purveyor of fine scrubs and lab coats, for sponsoring the contest.

New Facebook page

Main topic

Tech topic

Heartbleed security flaw